Bayer Receivables 2010-2024 | BAYRY

Bayer receivables for the quarter ending December 31, 2024 were $13.524B, a 2.49% decline year-over-year.

  • Bayer receivables for 2024 were $13.524B, a 2.49% decline from 2023.
  • Bayer receivables for 2023 were $13.87B, a 4.21% decline from 2022.
  • Bayer receivables for 2022 were $14.479B, a 7.86% decline from 2021.

Bayer Receivables 2010-2024 | BAYRY

  • Bayer receivables for 2024 were $13.524B, a 2.49% decline from 2023.
  • Bayer receivables for 2023 were $13.87B, a 4.21% decline from 2022.
  • Bayer receivables for 2022 were $14.479B, a 7.86% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Innoviva (INVA)$1.1B